Schott Pharma AG KGaASHTPY -42.88%64 Interest Coverage is 9.86 as of Mar. 2026, which is 72% below its 10-year median of 35.64. GuruFocus rates SHTPY with a GF Score™ of 64/100 and a GF Value™ of $7.02. The stock has 2 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Schott Pharma AG KGaA ranks worse than 59.01% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Schott Pharma AG KGaA's
Operating Income
for the
three
months ended in Mar. 2026 was $46 Mil. Schott Pharma AG KGaA's Interest Expense for the
three
months ended in Mar. 2026 was $-5 Mil.
Schott Pharma AG KGaA's interest coverage for the quarter that ended in Mar. 2026 was 9.86.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Schott Pharma AG KGaA's Interest Coverage or its related term are showing as below:
SHTPY'
s Interest Coverage Range Over the Past 10 Years
Min: 9.34 Med: 35.64 Max: 68.85
Current: 9.8
SHTPY's Interest Coverage is ranked worse than 59.01% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs SHTPY: 9.80
Schott Pharma AG KGaA (OTCPK:SHTPY) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Schott Pharma AG KGaA Interest Coverage Related Terms
Schott Pharma AG KGaA Interest Coverage Historical Data
* Premium members only.
The historical data trend for Schott Pharma AG KGaA's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
SHTPY vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Schott Pharma AG KGaA Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Schott Pharma AG KGaA's Interest Coverage falls into.
Schott Pharma AG KGaA Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Schott Pharma AG KGaA (SHTPY) has a Interest Coverage of 9.86 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Schott Pharma AG KGaA and its competitors. This is 72% below median its historical median of 35.64. Over the past decade, Schott Pharma AG KGaA's Interest Coverage has ranged from 9.34 to 68.85. According to the industry distribution chart, Schott Pharma AG KGaA ranks #275 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 59%.
Is Schott Pharma AG KGaA's Interest Coverage too high?
Schott Pharma AG KGaA's current Interest Coverage of 9.86 is 72% below median its 10-year median of 35.64. Over the past 10 years, this metric has ranged from a low of 9.34 to a high of 68.85. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Schott Pharma AG KGaA's value of 9.86 is 37.9% below this industry median. Based on the distribution chart, Schott Pharma AG KGaA ranks #275 out of 466 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Schott Pharma AG KGaA has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Schott Pharma AG KGaA's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Schott Pharma AG KGaA ranks #275 out of 466 companies for Interest Coverage. This places Schott Pharma AG KGaA in the lower half of its industry. The industry median Interest Coverage is 15.88. Schott Pharma AG KGaA's value of 9.86 is 37.9% below this benchmark. Historically, Schott Pharma AG KGaA's own Interest Coverage has ranged from 9.34 to 68.85 over the past decade. While the company's 10-year median is 35.64 vs. the industry median of 15.88, Schott Pharma AG KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Schott Pharma AG KGaA's current Interest Coverage of 9.86 is 37.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Schott Pharma AG KGaA and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Schott Pharma AG KGaA's current Interest Coverage is 9.86, which is 72% below median its own 10-year median of 35.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schott Pharma AG KGaA stock overvalued right now?
Schott Pharma AG KGaA (SHTPY) has a current Interest Coverage of 9.86. The stock's GF Value™ is $7.02, compared to a current price of $4.37 — trading 37.7% below its estimated fair value. The current Interest Coverage is 9.86, which is 72% below median its 10-year median of 35.64 and 37.9% below the Medical Devices & Instruments industry median of 15.88. Schott Pharma AG KGaA's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Schott Pharma AG KGaA (SHTPY), the current Interest Coverage is 9.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Schott Pharma AG KGaA (SHTPY) Overvalued in 2026?
Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued.
The current stock price of $4.37 is trading 37.7% below its estimated GF Value™ of $7.02.
Key valuation signals for SHTPY:
Interest Coverage: 9.86 (72% below median its 10-year median of 35.64)
GF Value™: $7.02 vs. price of $4.37 (37.7% below fair value)
Industry Position: 37.9% below the Medical Devices & Instruments median (#275 of 466)
No single metric tells the full story. See the SHTPY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
64GF Score
Get the complete analysis for SHTPY
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHTPY has been successfully added to your 
